News | Breast Density | February 14, 2019

Teleradiology provider will be first U.S. beta user for new densitasquality solution to enhance communication and compliance with FDA EQUIP mammography inspection program

Densitas Enters Partnership Agreement With TeleMammography Specialists

February 14, 2019 — Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography Specialists of Decatur, Ga. TeleMammography Specialists will be the first U.S. beta user for the new densitasquality solution from Densitas, which will be used to improve the communications and information sharing needed to meet EQUIP (Enhancing Quality Using the Inspection Program) guidelines. TeleMammography Specialists will also implement the recently released densitasdensity automated breast density assessment software.

Densitas will highlight the benefits and capabilities of both products at the 2019 Healthcare Information and Management Systems Society (HIMSS) annual meeting, Feb. 11-15 in Orlando, Fla.

TeleMammography Specialists LLC. is an international teleradiology services provider that is specialized in breast imaging. Densitas Quality will help:

  • Streamline efforts to meet the U.S. Food and Drug Administration’s (FDA) EQUIP guidelines and prepare for mammography inspections;
  • Enable real-time feedback from the interpreting physicians to the technologists;
  • Automate EQUIP audit documentation requirements of the lead interpreting physician/auditing physician;
  • Simplify the ability to meet the proactive quality control requirements of EQUIP; and
  • Identify technologist performance issues quickly and accurately to facilitate ongoing training and communication that improves image and service quality.

By making densitasquality and densitasdensity available to all of TeleMammography Specialists clients, over 60,000 women will benefit annually. "Densitas will help us provide consistent quality and standardize density assessment among our radiologists", said Martha H. Garrison, M.D., president and CEO of TeleMammography Specialists, LLC. "We will be able to more proactively manage the needs of our clients and provide consistently high quality of care."

The artificial intelligence (AI)-powered densitasdensity software delivers fully automated, standardized and reliably reproducible breast density assessment. Additionally, densitasdensity results can be incorporated in risk models to generate standardized and reliably reproducible breast cancer risk assessment.

For more information: www.densitas.health


Related Content

News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
Feature | Women's Health | Christine Murray

In breast cancer detection, speed and accuracy are more than clinical goals – they can significantly increase chances ...

Time June 17, 2025
arrow
News | Digital Pathology

June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to ...

Time June 12, 2025
arrow
News | Lung Imaging

June 11, 2025 — To prepare healthcare workforces and providers for an AI-driven future, Qure.ai has expanded its Global ...

Time June 11, 2025
arrow
News | Radiology Imaging

June 10, 2025 — CIVIE has announced the official launch of RadPod, an AI-driven, on-demand radiology platform designed ...

Time June 10, 2025
arrow
News | Ultrasound Imaging

June 4, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health ...

Time June 09, 2025
arrow
News | Mammography

June 9, 2025 — A new independent, peer-reviewed study published in the journal Clinical Breast Cancer reinforces the ...

Time June 09, 2025
arrow
News | Imaging Software Development

June 05, 2025 — Nano-X Imaging Ltd. has announced that its deep-learning medical imaging analytics subsidiary, Nanox AI ...

Time June 05, 2025
arrow
News | Prostate Cancer

June 5, 2025 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time June 05, 2025
arrow
Subscribe Now